Answer
Spevigo (spesolimab) 450 mg concentrate for solution for infusion is normally administered as a continuous intravenous infusion over 90 minutes after dilution; if slowed or temporarily stopped, total infusion time, including stops, must not exceed 180 minutes.
Sources for this answer
- Spevigo 450 mg concentrate for solution for infusionLeo Laboratories Limited · emc · SmPC §4.2 Posology and method of administration · Version 9Document updated
Sources checked